Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Acquisitions & Divestments (2016 - 2021)

Historic Change in Acquisitions & Divestments for Immucell (ICCC) over the last 11 years, with Q1 2021 value amounting to -$996000.0.

  • Immucell's Change in Acquisitions & Divestments rose 4931.3% to -$996000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$996000.0, marking a year-over-year increase of 7112.21%. This contributed to the annual value of -$996000.0 for FY2021, which is 7112.21% up from last year.
  • Latest data reveals that Immucell reported Change in Acquisitions & Divestments of -$996000.0 as of Q1 2021, which was up 4931.3% from -$996000.0 recorded in Q4 2020.
  • Immucell's 5-year Change in Acquisitions & Divestments high stood at $2.7 million for Q1 2017, and its period low was -$11.6 million during Q3 2019.
  • Over the past 4 years, Immucell's median Change in Acquisitions & Divestments value was -$996000.0 (recorded in 2020), while the average stood at -$1.5 million.
  • Over the last 5 years, Immucell's Change in Acquisitions & Divestments had its largest YoY gain of 45060.48% in 2017, and its largest YoY loss of 7545.36% in 2017.
  • Quarter analysis of 4 years shows Immucell's Change in Acquisitions & Divestments stood at $487000.0 in 2017, then tumbled by 1063.86% to -$4.7 million in 2019, then skyrocketed by 78.78% to -$996000.0 in 2020, then changed by 0.0% to -$996000.0 in 2021.
  • Its last three reported values are -$996000.0 in Q1 2021, -$996000.0 for Q4 2020, and -$2.0 million during Q3 2020.